Related Experiment Video
Updated: May 30, 2026

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body
Published on: January 11, 2018
Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in
Anna Vecchiarelli1, Eva Pericolini, Elena Gabrielli
1Microbiology Section, Department of Experimental Medicine & Biochemical Sciences, University of Perugia, Via del Giochetto, 06126 Perugia, Italy. vecchiar@unipg.it
Abstract:
Cryptococcus neoformans is an opportunistic fungal pathogen responsible for life-threatening infections in immunocompromised individuals and occasionally in those with no known immune impairment. The fungus is endowed with several virulence factors, including capsular polysaccharides that play a key role in virulence. The capsule is composed of 90-95% glucuronoxylomannan (GXM), 5-8% galactoxylomannan (GalXM) and <1% mannoproteins. Capsular polysaccharides are shed into tissue where they produce many deleterious effects. Since GalXM has a smaller molecular mass, the molar concentration of GalXM in polysaccharide that is shed could exceed that of GXM in C. neoformans exopolysaccharides. Moreover, GalXM exhibits a number of unusual biologic properties both in vitro and in vivo. Here, we summarize the principal immunomodulatory effects of GalXM described during the last 20 years, particularly the mechanisms leading to induction of apoptosis in T lymphocytes, B lymphocytes and macrophages. Since the capacity of GalXM to induce widespread immune suppression is believed to contribute to the virulence of C. neoformans, this property might be exploited therapeutically to dampen the aberrant activation of immune cells during autoimmune disorders.
Insights
Galactoxylomannan (GalXM), a component of Cryptococcus neoformans, induces apoptosis in immune cells, contributing to fungal virulence. This immune suppression offers potential therapeutic applications for autoimmune diseases.
Area of Science:
- Mycology
- Immunology
- Pathogen Biology
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen causing severe infections.
- Its virulence is linked to capsular polysaccharides, primarily glucuronoxylomannan (GXM) and galactoxylomannan (GalXM).
- GalXM, despite its lower concentration, has unique biological properties and is shed in tissues.
Purpose of the Study:
- To review the immunomodulatory effects of GalXM over the past two decades.
- To elucidate the mechanisms by which GalXM induces apoptosis in immune cells.
- To explore the therapeutic potential of GalXM's immunosuppressive properties.
Main Methods:
- Literature review of studies on GalXM's immunomodulatory effects.
- Analysis of mechanisms of apoptosis induction in lymphocytes and macrophages.
- Evaluation of GalXM's role in C. neoformans virulence.
Main Results:
- GalXM induces apoptosis in T lymphocytes, B lymphocytes, and macrophages.
- This induction of apoptosis contributes to immune suppression and C. neoformans virulence.
- GalXM's smaller molecular mass may lead to higher molar concentrations when shed.
Conclusions:
- GalXM possesses significant immunomodulatory capabilities, primarily through inducing apoptosis.
- The immunosuppressive effects of GalXM are a key factor in C. neoformans pathogenesis.
- GalXM's properties may be harnessed for treating autoimmune disorders characterized by immune cell overactivation.
Related Concept Videos
Cryptococcal Meningitis
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
